Physician profile
Edward E Lee
NPI 1144394966
$12,932.44
in general payments reported to CMS, 2019-2025
37 companies · $1,333 in 2025
The $1,333 reported for 2025 was more than what 84% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,677 · 2020: $1,080 · 2021: $963 · 2022: $878 · 2023: $1,040 · 2024: $1,961 · 2025: $1,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,296 · Education: $38.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,296.17 |
| Education | $38.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $5,395.60 | 2019-2025 | Otezla, Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $1,463.08 | 2019-2025 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $737.86 | 2022-2025 | |
| Abbvie INC. | $494.93 | 2019-2025 | |
| Lilly USA, LLC | $456.22 | 2019-2025 | Mounjaro, Zepbound |
| Vifor Pharma, INC. | $433.43 | 2019-2025 | Veltassa, Korsuva |
| Novo Nordisk INC | $411.03 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $405.99 | 2019-2025 | Jynarque, Voyxact |
| Gilead Sciences, INC. | $403.86 | 2019-2025 | |
| Opko Pharmaceuticals, LLC | $393.85 | 2021-2025 | Rayaldee |
| Amarin Pharma, INC. | $337.49 | 2019-2022 | |
| Travere Therapeutics, INC. | $298.84 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $176.36 | 2021-2025 | |
| Medtronic, INC. | $158.37 | 2024 | Cobalt Dr Mri Surescan |
| Fresenius USA Marketing, INC. | $157.03 | 2019-2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.